Found: 72
Select item for more details and to access through your institution.
Transmission of parvovirus B19 by coagulation factor concentrates exposed to 100 degrees C heat after lyophilization.
- Published in:
- 1997
- By:
- Publication type:
- journal article
Transmission of parvovirus B19 by coagulation factor concentrates exposed to 100°C heat after lyophilization.
- Published in:
- Transfusion, 1997, v. 37, n. 5, p. 517, doi. 10.1046/j.1537-2995.1997.37597293884.x
- By:
- Publication type:
- Article
TRANSFUSION COMPLICATIONS Sustained suppression of hepatitis C virus by high doses of interferon and ribavirin in adult hemophilic patients.
- Published in:
- Transfusion, 2004, v. 44, n. 5, p. 790, doi. 10.1111/j.1537-2995.2004.03154.x
- By:
- Publication type:
- Article
Nef-specific CD45RA+ CD8+ T cells secreting MIP-1ß but not IFN-gamma are associated with nonprogressive HIV-1 infection.
- Published in:
- 2010
- By:
- Publication type:
- Journal Article
Prophylaxis re‐visited: The potential impact of novel factor and non‐factor therapies on prophylaxis.
- Published in:
- Haemophilia, 2018, v. 24, n. 6, p. 845, doi. 10.1111/hae.13558
- By:
- Publication type:
- Article
Pharmacokinetic modelling and validation of the half‐life extension needed to reduce the burden of infusions compared with standard factor VIII.
- Published in:
- Haemophilia, 2018, v. 24, n. 3, p. 376, doi. 10.1111/hae.13483
- By:
- Publication type:
- Article
Defining extended half‐life rFVIII—A critical review of the evidence.
- Published in:
- Haemophilia, 2018, v. 24, n. 3, p. 348, doi. 10.1111/hae.13438
- By:
- Publication type:
- Article
Comorbidities in persons with haemophilia aged 60 years or more compared with age‐matched people from the general population.
- Published in:
- Haemophilia, 2018, v. 24, n. 1, p. e6, doi. 10.1111/hae.13379
- By:
- Publication type:
- Article
Pattern of bleeding in a large prospective cohort of haemophilia A patients: A three‐year follow‐up of the AHEAD (Advate in HaEmophilia A outcome Database) study.
- Published in:
- Haemophilia, 2018, v. 24, n. 1, p. 85, doi. 10.1111/hae.13361
- By:
- Publication type:
- Article
Polypharmacy in older adults with severe haemophilia.
- Published in:
- Haemophilia, 2018, v. 24, n. 1, p. e1, doi. 10.1111/hae.13262
- By:
- Publication type:
- Article
Ageing successfully with haemophilia: A multidisciplinary programme.
- Published in:
- Haemophilia, 2018, v. 24, n. 1, p. 57, doi. 10.1111/hae.13308
- By:
- Publication type:
- Article
First report on the safety and efficacy of an extended half-life glyco PEGylated recombinant FVIII for major surgery in severe haemophilia A.
- Published in:
- Haemophilia, 2017, v. 23, n. 5, p. 689, doi. 10.1111/hae.13246
- By:
- Publication type:
- Article
Involvement of the IgE-basophil system and mild complement activation in haemophilia B with anti-factor IX neutralizing antibodies and anaphylaxis.
- Published in:
- Haemophilia, 2017, v. 23, n. 4, p. e348, doi. 10.1111/hae.13282
- By:
- Publication type:
- Article
Pharmacokinetics of a novel extended half-life glyco PEGylated factor IX, nonacog beta pegol (N9- GP) in previously treated patients with haemophilia B: results from two phase 3 clinical trials.
- Published in:
- Haemophilia, 2017, v. 23, n. 4, p. 547, doi. 10.1111/hae.13191
- By:
- Publication type:
- Article
Insight into health-related quality of life of young children with haemophilia B treated with long-acting nonacog beta pegol recombinant factor IX.
- Published in:
- Haemophilia, 2017, v. 23, p. e222, doi. 10.1111/hae.13195
- By:
- Publication type:
- Article
New Findings on Inhibitor Development: from Registries to Clinical Studies.
- Published in:
- Haemophilia, 2017, v. 23, p. 4, doi. 10.1111/hae.13137
- By:
- Publication type:
- Article
European retrospective study of real-life haemophilia treatment.
- Published in:
- Haemophilia, 2017, v. 23, n. 1, p. 105, doi. 10.1111/hae.13111
- By:
- Publication type:
- Article
Long-term outcome of haemophilia A patients after successful immune tolerance induction therapy using a single plasma-derived FVIII/VWF product: the long-term ITI study.
- Published in:
- Haemophilia, 2016, v. 22, n. 6, p. 859, doi. 10.1111/hae.12986
- By:
- Publication type:
- Article
Daclatasvir/peginterferon lambda-1a/ribavirin in patients with chronic HCV infection and haemophilia who are treatment naïve or prior relapsers to peginterferon alfa-2a/ribavirin.
- Published in:
- Haemophilia, 2016, v. 22, n. 5, p. 692, doi. 10.1111/hae.12947
- By:
- Publication type:
- Article
Comparative pharmacokinetics of rVIII-SingleChain and octocog alfa (Advate<sup>®</sup>) in patients with severe haemophilia A.
- Published in:
- Haemophilia, 2016, v. 22, n. 5, p. 730, doi. 10.1111/hae.12985
- By:
- Publication type:
- Article
Interim results from a large multinational extension trial (guardian<sup>™</sup>2) using turoctocog alfa for prophylaxis and treatment of bleeding in patients with severe haemophilia A.
- Published in:
- Haemophilia, 2016, v. 22, n. 5, p. e445, doi. 10.1111/hae.12990
- By:
- Publication type:
- Article
Efficacy and safety of long-acting recombinant fusion protein linking factor IX with albumin in haemophilia B patients undergoing surgery.
- Published in:
- Haemophilia, 2016, v. 22, n. 4, p. e259, doi. 10.1111/hae.12972
- By:
- Publication type:
- Article
The thrombin generation assay distinguishes inhibitor from non-inhibitor patients with severe haemophilia A.
- Published in:
- Haemophilia, 2016, v. 22, n. 4, p. e286, doi. 10.1111/hae.12927
- By:
- Publication type:
- Article
Low thrombin generation during major orthopaedic surgery fails to predict the bleeding risk in inhibitor patients treated with bypassing agents.
- Published in:
- Haemophilia, 2016, v. 22, n. 4, p. e292, doi. 10.1111/hae.12939
- By:
- Publication type:
- Article
Clinical overview of Fanhdi/Alphanate (plasma-derived, VWF-containing FVIII concentrate) in immune tolerance induction in haemophilia A patients with inhibitors.
- Published in:
- Haemophilia, 2016, v. 22, n. 1, p. e71, doi. 10.1111/hae.12857
- By:
- Publication type:
- Article
Results of a phase I/II open-label, safety and efficacy trial of coagulation factor IX (recombinant), albumin fusion protein in haemophilia B patients.
- Published in:
- Haemophilia, 2015, v. 21, n. 6, p. 784, doi. 10.1111/hae.12721
- By:
- Publication type:
- Article
Long-term patterns of safety and efficacy of bleeding prophylaxis with turoctocog alfa (NovoEight<sup>®</sup>) in previously treated patients with severe haemophilia A: interim results of the guardian<sup>™</sup>2 extension trial.
- Published in:
- Haemophilia, 2015, v. 21, n. 5, p. e436, doi. 10.1111/hae.12737
- By:
- Publication type:
- Article
Safety and efficacy of turoctocog alfa (NovoEight<sup>®</sup>) during surgery in patients with haemophilia A: results from the multinational guardian<sup>™</sup> clinical trials.
- Published in:
- Haemophilia, 2015, v. 21, n. 1, p. 34, doi. 10.1111/hae.12518
- By:
- Publication type:
- Article
Continuous infusion of recombinant factor VIII formulated with sucrose in surgery: Non-interventional, observational study in patients with severe haemophilia A.
- Published in:
- Haemophilia, 2015, v. 21, n. 1, p. e19, doi. 10.1111/hae.12530
- By:
- Publication type:
- Article
Pharmacokinetics, phenotype and product choice in haemophilia B: how to strike a balance?
- Published in:
- Haemophilia, 2014, v. 20, p. 1, doi. 10.1111/hae.12556
- By:
- Publication type:
- Article
Adult haemophilia A patients with inhibitors: successful immune tolerance induction with a single FVIII/VWF product.
- Published in:
- Haemophilia, 2014, v. 20, n. 6, p. e414, doi. 10.1111/hae.12521
- By:
- Publication type:
- Article
New predictive approaches for ITI treatment.
- Published in:
- Haemophilia, 2014, v. 20, n. 6, p. 27, doi. 10.1111/hae.12467
- By:
- Publication type:
- Article
Assessment of the impact of treatment on quality of life of patients with haemophilia A at different ages: insights from two clinical trials on turoctocog alfa.
- Published in:
- Haemophilia, 2014, v. 20, n. 4, p. 527, doi. 10.1111/hae.12371
- By:
- Publication type:
- Article
Inhibitors - genetic and environmental factors.
- Published in:
- Haemophilia, 2014, v. 20, p. 87, doi. 10.1111/hae.12412
- By:
- Publication type:
- Article
Inhibitors - genetic and environmental factors.
- Published in:
- Haemophilia, 2014, v. 20, p. 87, doi. 10.1111/hae.12412
- By:
- Publication type:
- Article
Switching clotting factor concentrates: considerations in estimating the risk of immunogenicity.
- Published in:
- Haemophilia, 2014, v. 20, n. 2, p. 200, doi. 10.1111/hae.12283
- By:
- Publication type:
- Article
Integrated postural analysis in children with haemophilia.
- Published in:
- Haemophilia, 2014, v. 20, n. 2, p. 263, doi. 10.1111/hae.12369
- By:
- Publication type:
- Article
Primary and rescue immune tolerance induction in children and adults: a multicentre international study with a VWF-containing plasma-derived FVIII concentrate.
- Published in:
- Haemophilia, 2014, v. 20, n. 1, p. 83, doi. 10.1111/hae.12263
- By:
- Publication type:
- Article
Results from a large multinational clinical trial (guardian™3) using prophylactic treatment with turoctocog alfa in paediatric patients with severe haemophilia A: safety, efficacy and pharmacokinetics.
- Published in:
- Haemophilia, 2013, v. 19, n. 5, p. 698, doi. 10.1111/hae.12165
- By:
- Publication type:
- Article
Real-world outcomes with recombinant factor VIIa treatment of acute bleeds in haemophilia patients with inhibitors: results from the international ONE registry.
- Published in:
- Haemophilia, 2013, v. 19, n. 4, p. 571, doi. 10.1111/hae.12140
- By:
- Publication type:
- Article
Models for institutional and professional accreditation of haemophilia centres in Italy.
- Published in:
- Haemophilia, 2013, v. 19, n. 4, p. e248, doi. 10.1111/hae.12141
- By:
- Publication type:
- Article
More than a decade of international experience with a pdFVIII/VWF concentrate in immune tolerance.
- Published in:
- Haemophilia, 2013, v. 19, p. 8, doi. 10.1111/hae.12050
- By:
- Publication type:
- Article
Management of bleeding disorders: basic science.
- Published in:
- Haemophilia, 2012, v. 18, p. 8, doi. 10.1111/j.1365-2516.2012.02795.x
- By:
- Publication type:
- Article
Thrombotic adverse events to coagulation factor concentrates for treatment of patients with haemophilia and von Willebrand disease: a systematic review of prospective studies.
- Published in:
- Haemophilia, 2012, v. 18, n. 3, p. e173, doi. 10.1111/j.1365-2516.2012.02758.x
- By:
- Publication type:
- Article
Non-thrombotic-, non-inhibitor-associated adverse reactions to coagulation factor concentrates for treatment of patients with hemophilia and von Willebrand's disease: a systematic review of prospective studies.
- Published in:
- Haemophilia, 2012, v. 18, n. 3, p. e164, doi. 10.1111/j.1365-2516.2011.02745.x
- By:
- Publication type:
- Article
Bioequivalence between two serum-free recombinant factor VIII preparations (N8 and ADVATE<sup>®</sup>) - an open-label, sequential dosing pharmacokinetic study in patients with severe haemophilia A.
- Published in:
- Haemophilia, 2011, v. 17, n. 6, p. 854, doi. 10.1111/j.1365-2516.2011.02495.x
- By:
- Publication type:
- Article
When should prophylaxis therapy in inhibitor patients be considered?
- Published in:
- Haemophilia, 2011, v. 17, n. 5, p. e849, doi. 10.1111/j.1365-2516.2011.02494.x
- By:
- Publication type:
- Article
The need for speed in the management of haemophilia patients with inhibitors.
- Published in:
- Haemophilia, 2011, v. 17, n. 1, p. 95, doi. 10.1111/j.1365-2516.2010.02265.x
- By:
- Publication type:
- Article
Dental surgery in inherited bleeding disorders with minimal factor support: commentary.
- Published in:
- Haemophilia, 2011, v. 17, n. 1, p. e183, doi. 10.1111/j.1365-2516.2010.02341.x
- By:
- Publication type:
- Article
F8 mRNA studies in haemophilia A patients with different splice site mutations.
- Published in:
- Haemophilia, 2010, v. 16, n. 5, p. 786, doi. 10.1111/j.1365-2516.2010.02250.x
- By:
- Publication type:
- Article